RICHARD GERSH: Open Payments
NPI 1942247994 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 17 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $132 · 2025 $839
Food & beverage: $737Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $303 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $204 |
| E.R. Squibb & Sons, L.L.C. | 4 | $163 |
| Alkermes, Inc. | 4 | $136 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
Products named: CAPLYTA, UZEDY, COBENFY, LYBALVI, ABILIFY MAINTENA, VIVITROL, ARISTADA.
Industry payments across NY — which companies pay providers there.
